Bilateral carotid filter implants to prevent repeat large-artery embolic strokes in people with atrial fibrillation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized study compares standard oral anticoagulation alone versus oral anticoagulation plus bilateral Vine carotid filter implants in patients with atrial fibrillation who had an ischemic stroke within the past year. The filters are placed in both common carotid arteries and have been shown in laboratory testing to capture emboli ≥1.4 mm and some smaller particles. Investigators expect the implants to prevent most emboli from reaching the anterior circulation, where the majority of large-vessel occlusions occur, while recognizing the posterior circulation will not be protected. Participants must meet carotid diameter and access criteria on imaging and be able to take single antiplatelet therapy alongside anticoagulation for a limited period.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Documented history of clinical AF
2. History of ischemic (i.e. non-hemorrhagic) stroke including symptoms of stroke resolving within 24 hours with positive neuro-imaging, meeting one of the following criteria:

   Group 1: Patient was on OAC at time of index stroke, with index stroke occurring \< 6 week from enrollment Group 2: Patient was not on OAC at time of stroke, with index stroke occurring \< 6 weeks from enrollment Group 3: Patient was on OAC at time of index stroke, with index stroke occurring 6 to 52 weeks from enrollment
3. Planned use of a Vitamin K antagonist (VKA) or a direct oral anticoagulant (DOAC) for the duration of the trial
4. Patient able to tolerate single antiplatelet therapy in addition to oral anticoagulation for 6 months, in the opinion of the investigator
5. Bilateral ultrasound or angiogram demonstrating all of the following:

   1. Inner common carotid artery diameter range: ≥5.3 mm and ≤8.8 mm
   2. Accessibility: up to 40 mm from skin to common carotid artery center
   3. Implantation segment free of any atherosclerotic disease
   4. Absence of carotid dissection or pre-existing stent(s) in common carotid artery
   5. Absence of ≥50% stenosis of the internal carotid arteries as seen on ultrasound or angiography (CTA, MRA or DSA)

   i. For ultrasound, calculate the percentage of carotid stenosis using the Society of Radiologists in Ultrasound Consensus Criteria for Carotid Stenosis, where ≥50% stenosis is defined by internal carotid artery peak systolic velocity of ≥125 cm/sec, internal/common carotid peak systolic velocity ratio of 2 or more and end diastolic velocity of ≥40 cm/sec, or evidence of near occlusion.

   ii. For angiography, calculate the percentage of carotid stenosis using the North American Symptomatic Carotid Endarterectomy Trial (NASCET) criteria (\[D - N\]/D x 100, where N is the luminal diameter at the site of maximal narrowing and D is the diameter of normal distal internal carotid artery beyond the bulb where the artery walls are parallel.
6. Provision of informed consent

Exclusion Criteria:

1. Contraindication to oral anticoagulation (e.g. history of intracranial hemorrhage, known hereditary or acquired coagulation disorders, or recurrent major bleeding)
2. Contraindication to additional single antiplatelet therapy for 6 months from randomization
3. Previously documented 50% or greater stenosis, or high-risk plaque in the opinion of the investigator, of the common carotid, internal carotid, subclavian, vertebral, or intracranial arteries that has not been treated with a revascularization procedure (i.e. stent or angioplasty)
4. Visualized active (acute/subacute) cervical or intracranial arterial thrombus (i.e. free-floating) on computed tomography (CT), magnetic resonance (MR), or digital subtraction (DS) angiography that is at risk of causing additional stroke/brain injury
5. Previously documented aneurysm of the internal carotid artery or its branches (i.e. ophthalmic, posterior communicating, anterior choroidal, anterior cerebral and middle cerebral arteries) that is 6 mm or greater in diameter.
6. Prior surgery or radiation of the neck at the implantation segment
7. Pre-existing percutaneous left atrial appendage occlusion device that was implanted after most recent ischemic stroke
8. Planned left atrial appendage occlusion procedure
9. Female who is pregnant or non-postmenopausal female who is not willing to use an effective method of birth control during duration of the trial
10. Overt systemic infection
11. Known sensitivity to nickel or titanium metals, or their alloys
12. Active participation in another investigational drug or device treatment trial
13. Any other condition that in the opinion of the investigator may adversely affect the safety of the patient or would limit the patient's ability to complete the trial

Where it's running

• Mercyhealth Javon Bea Hospital - Riverside
  Rockford, Illinois, United States Recruiting
• Boston University Medical Center
  Boston, Massachusetts, United States Recruiting
• Weill Cornell Medical Center
  New York, New York, United States Recruiting
• Erlanger Medical Center
  Chattanooga, Tennessee, United States Recruiting
• Hamilton General Hospital
  Hamilton, Canada, Canada Recruiting
• University Hospital
  London, Ontario, Canada Recruiting

Study contacts

• Principal investigator: Ashkan Shoamanesh, MD, FRCPC — Population Health Research Institute, McMaster University
• Study coordinator: Sagit Broder, MSc
• Email: sagit@javelinmed.com
• Phone: +972587112116

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals

  This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.

  Recruiting at 2 sites Hospital Universitari Vall d'Hebron Research Institute · Leuven and 6 other locations · NCT07924371

• Apixaban with or without Clopidogrel in stroke patients with NVAF and intracranial/extracranial atherosclerosis

  This study tests whether adding clopidogrel to apixaban is safe and helpful for people with acute ischemic stroke due to non-valvular atrial fibrillation and atherosclerosis.

  Recruiting Phase 4 Yonsei University · Seoul · NCT07237308

• Deep phenotyping to explore recovery in young adults after stroke

  This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.

  Recruiting The Florey Institute of Neuroscience and Mental Health · Heidelberg, Victoria and 1 other locations · NCT07019493

• Heart assessment to check repeat-stroke risk in people with atrial fibrillation

  This project will test whether detailed heart examinations can find which people with atrial fibrillation who just had an ischemic stroke are at high risk of having another stroke.

  Recruiting Insel Gruppe AG, University Hospital Bern · Bern · NCT06954610

• Stem cell therapy for chronic stroke recovery

  This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.

  Recruiting Phase 2 Hokkaido University Hospital · Sapporo, Hokkaido · NCT06752720

• B2AD-Risk: How atrial fibrillation burden changes after ischemic stroke

  This project will try continuous implantable heart-rhythm monitoring to see how atrial fibrillation changes over time in people newly diagnosed with AF after an ischemic stroke.

  Recruiting London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · London, Ontario · NCT06589700

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.